PA8506101A1 - USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION - Google Patents

USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION

Info

Publication number
PA8506101A1
PA8506101A1 PA20008506101A PA8506101A PA8506101A1 PA 8506101 A1 PA8506101 A1 PA 8506101A1 PA 20008506101 A PA20008506101 A PA 20008506101A PA 8506101 A PA8506101 A PA 8506101A PA 8506101 A1 PA8506101 A1 PA 8506101A1
Authority
PA
Panama
Prior art keywords
acat
manufacture
compound
pharmaceutical composition
aterosclerotic
Prior art date
Application number
PA20008506101A
Other languages
Spanish (es)
Inventor
Thomas Michael Andrew Bocan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PA8506101A1 publication Critical patent/PA8506101A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

ESTA INVENCION ES LA ADMINISTRACION DE UN INHIBIDOR ACAT PARA PREVENIR LA ACUMULACION DE MONOCITO-MACROFAGO Y LA EXPRESION MMP EN LAS LESIONES ATEROSCLEROTICAS. ADEMAS, ESTA INVENCION SE RELACIONA CON METODOS PARA INHIBIR LA DESESTABILIZACION Y/O RUPTURA DE PLACAS ATEROSCLEROTICAS Y EL TRATAMIENTO DE LA ANGINA INESTABLE.THIS INVENTION IS THE ADMINISTRATION OF AN ACAT INHIBITOR TO PREVENT ACCUMULATION OF MONOCITO-MACROFAGO AND MMP EXPRESSION IN ATEROSCLEROTIC INJURIES. IN ADDITION, THIS INVENTION IS RELATED TO METHODS FOR INHIBITING DISSTABILIZATION AND / OR RUPTURE OF ATEROSCLEROTIC PLATES AND THE TREATMENT OF THE UNSTABLE ANGINA.

PA20008506101A 1999-11-05 2000-11-01 USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION PA8506101A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16381499P 1999-11-05 1999-11-05

Publications (1)

Publication Number Publication Date
PA8506101A1 true PA8506101A1 (en) 2002-10-28

Family

ID=22591694

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008506101A PA8506101A1 (en) 1999-11-05 2000-11-01 USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION

Country Status (19)

Country Link
EP (1) EP1229907A1 (en)
JP (1) JP2003513909A (en)
KR (1) KR20020050257A (en)
CN (1) CN1414848A (en)
AR (1) AR026354A1 (en)
AU (1) AU1210401A (en)
CA (1) CA2382676A1 (en)
CO (1) CO5270017A1 (en)
GT (1) GT200000193A (en)
HU (1) HUP0203160A3 (en)
IL (1) IL149145A0 (en)
PA (1) PA8506101A1 (en)
PE (1) PE20011027A1 (en)
PL (1) PL355148A1 (en)
SV (1) SV2001000207A (en)
TR (1) TR200201204T2 (en)
UY (1) UY26427A1 (en)
WO (1) WO2001034127A1 (en)
ZA (1) ZA200201755B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060111898A (en) 2003-08-29 2006-10-30 교와 가부시키가이샤 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
US20080044404A1 (en) * 2004-04-15 2008-02-21 Anna Cederholm Annexin V for Preventing Atherothrombosis and Plaque Rupture
ES2775125T3 (en) 2010-11-03 2020-07-23 Dow Agrosciences Llc Pesticide compositions and related procedures
US8937083B2 (en) 2011-10-26 2015-01-20 DowAgroSciences, LLC Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
JP6189937B2 (en) 2012-04-27 2017-08-30 ダウ アグロサイエンシィズ エルエルシー Agrochemical compositions and methods relating thereto
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
JP2016536296A (en) 2013-10-17 2016-11-24 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
JP2016536295A (en) 2013-10-17 2016-11-24 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
CN105636446B (en) 2013-10-17 2018-07-13 美国陶氏益农公司 The method for preparing Pesticidal compound
KR20160072155A (en) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 Processes for the preparation of pesticidal compounds
JP2016535010A (en) 2013-10-17 2016-11-10 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
US9102655B2 (en) 2013-10-17 2015-08-11 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
KR20160072154A (en) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 Processes for the preparation of pesticidal compounds
EP3060052A4 (en) 2013-10-22 2017-04-05 Dow AgroSciences LLC Synergistic pesticidal compositions and related methods
AR098098A1 (en) 2013-10-22 2016-05-04 Dow Agrosciences Llc SYNERGIC PESTICIATED COMPOSITIONS AND RELATED METHODS
CN105828610B (en) 2013-10-22 2019-07-19 美国陶氏益农公司 Pesticidal combination and relative method
JP2016534086A (en) 2013-10-22 2016-11-04 ダウ アグロサイエンシィズ エルエルシー Synergistic pest control compositions and related methods
MX2016005316A (en) 2013-10-22 2017-03-01 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods.
CA2926438A1 (en) 2013-10-22 2015-04-30 Dow Agrosciences Llc Pesticidal compositions and related methods
MX2016005323A (en) 2013-10-22 2016-08-12 Dow Agrosciences Llc Pesticidal compositions and related methods.
JP2016535025A (en) 2013-10-22 2016-11-10 ダウ アグロサイエンシィズ エルエルシー Synergistic pest control compositions and related methods
WO2015061155A1 (en) 2013-10-22 2015-04-30 Dow Agrosciences Llc Pesticidal compositions and related methods
KR20160074621A (en) 2013-10-22 2016-06-28 다우 아그로사이언시즈 엘엘씨 Synergistic pesticidal compositions and related methods
CN105848480A (en) 2013-10-22 2016-08-10 美国陶氏益农公司 Synergistic pesticidal compositions and related methods
TW201519780A (en) 2013-10-22 2015-06-01 Dow Agrosciences Llc Pesticidal compositions and related methods
MX2016005325A (en) 2013-10-22 2016-08-08 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods.
EP3060055A4 (en) 2013-10-22 2017-03-29 Dow AgroSciences LLC Synergistic pesticidal compositions and related methods
US9808008B2 (en) 2013-10-22 2017-11-07 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
CA2927202A1 (en) 2013-10-22 2015-04-30 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
AU2014340430B2 (en) 2013-10-22 2017-05-25 Dow Agrosciences Llc Pesticidal compositions and related methods
CN106470976A (en) 2014-07-31 2017-03-01 美国陶氏益农公司 The method of preparation 3 (3 chlorine 1H pyrazoles 1 base) pyridine
EP3186229A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
EP3174856A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
US9024031B1 (en) 2014-08-19 2015-05-05 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
BR112017004613A2 (en) 2014-09-12 2017-12-05 Dow Agrosciences Llc Process for the preparation of 3- (3-chloro-1h-pyrazol-1-yl) pyridine
CA2961166C (en) * 2014-10-21 2021-04-13 Council Of Scientific And Industrial Research Alkylidene phosphonate esters as p-glycoprotein inducers
US20190275012A9 (en) * 2016-07-29 2019-09-12 Lupin Limited Substituted thiazolo-pyridine compounds as malt1 inhibitors
WO2018093966A1 (en) * 2016-11-16 2018-05-24 Purdue Research Foundation Compositions and methods for regulating body weight and metabolic syndromes
WO2018125817A1 (en) 2016-12-29 2018-07-05 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
EP3562807B1 (en) 2016-12-29 2022-08-03 Corteva Agriscience LLC Processes for the preparation of pesticidal compounds
CU20200038A7 (en) 2017-10-27 2021-03-11 Bayer Ag COMPOUNDS DERIVED FROM PYRAZOLO-PIRROLO-PYRIMIDINE-DIONA AS INHIBITORS OF P2X3
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2067254T3 (en) * 1990-10-30 1995-03-16 Warner Lambert Co OXISULFONILCARBAMATOS.
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
IT1270976B (en) * 1993-08-06 1997-05-26 Pierrel Spa INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
EE9800037A (en) * 1995-08-04 1998-08-17 Warner-Lambert Company Use of sulphamic acid derivatives, acylsulphonamides or sulphonylcarbamates in the manufacture of a medicament for reducing lipoprotein levels
WO1997016184A1 (en) * 1995-11-02 1997-05-09 Warner-Lambert Company Method and pharmaceutical composition for regulating lipid concentration
OA11584A (en) * 1998-07-21 2004-07-20 Warner Lambert Co Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions.

Also Published As

Publication number Publication date
WO2001034127A1 (en) 2001-05-17
CN1414848A (en) 2003-04-30
TR200201204T2 (en) 2002-08-21
PE20011027A1 (en) 2001-10-16
CO5270017A1 (en) 2003-04-30
PL355148A1 (en) 2004-04-05
GT200000193A (en) 2002-04-27
AU1210401A (en) 2001-06-06
CA2382676A1 (en) 2001-05-17
JP2003513909A (en) 2003-04-15
UY26427A1 (en) 2000-12-29
ZA200201755B (en) 2003-08-27
SV2001000207A (en) 2001-10-16
HUP0203160A3 (en) 2006-02-28
AR026354A1 (en) 2003-02-05
IL149145A0 (en) 2002-11-10
EP1229907A1 (en) 2002-08-14
KR20020050257A (en) 2002-06-26
HUP0203160A2 (en) 2003-01-28

Similar Documents

Publication Publication Date Title
PA8506101A1 (en) USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION
BR9909565A (en) Bicyclic derivatives of hydroxamic acid
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
PA8521701A1 (en) PIRAZOL DERIVATIVES
BR0212014A (en) Use of hydroxamic acid derivatives histone deacetylase inhibitors
CR7171A (en) PHARMACEUTICAL COMPOSITIONS OF NEUTRALIZED ACID PHARMACES AND POLYMERS
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
ES2193337T3 (en) USE OF STRONTIUM SALTS FOR THE TREATMENT OF ARTROSIS.
NO20025358D0 (en) Orthosubstituted anthranilic acid amides and their use as drugs
SE0101932D0 (en) Pharmaceutical combinations
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
PA8586801A1 (en) HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
BR0010546A (en) Anti-inflammatory therapy for inflammatory mediated infection
DOP2000000022A (en) COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES.
SE9801494D0 (en) Novel use
PT1150704E (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
BR0209155A (en) Pharmaceutical tablet having a high api content
ATE253359T1 (en) ANTITHRBOTIC AGENTS
SE0300445D0 (en) New combination
PA7801701A1 (en) ARYLTIUM COMPOUNDS
ECSP034485A (en) NEW SPECIFIC MECHANISM TO INHIBIT THE ADHESION OF PLATQUETS TO THE COLLAGEN
AR030660A1 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION
ES2182931T3 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE ON THE BASE OF KETOPROPHENE.
PA8469001A1 (en) MMP STATIN-INHIBITOR COMBINATIONS.
BR0114459A (en) Substituted 5-amino-1-penten-3-ol substituted derivatives